We are working on the following new projects:

• We were awarded with a bioequivalence trial of Ketorolac.
• We are signing contracts for bioequivalence trials with Glecaprevir+Pibrentasvir and Sofosbuvir.
• Smooth signed a contract for medical writing in BE trials with Rivaroxaban 2,5 mg, 10 mg and 20 mg.

We are happy to reach the following milestones in our projects:

• A clinical part was finished in the Nimesulide trial with dorsopathy.
• 7 subjects were randomized in India and 28 in Russia in the international phase III clinical trial of the original drug for the patients with chronic myeloid leukemia.
• 185 subjects were included in the phase III trial with postoperative pain.